서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 10 of 10

Issue DateTitle / Author(s) / CitationFileAltmetrics
2005
한국어 교육 자료에 나타난 한국 문화 -성인 대상 교육 자료를 중심으로-

김영란

국어교육연구, Vol.15, pp. 217-274

view file
2019-01
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
DOI
2019-01
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
view fileDOI
2022-08
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
DOI
2022-08
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
view filelink
2022-10
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea
DOI
2023-09
Chromatographic Determination of the Absolute Configuration in Sanjoinine A That Increases Nitric Oxide Production

Um, Soohyun; Jeong, Hyeongju; An, Joon Soo; Jo, Se Jin; Kim, Young Ran; Oh, Dong-Chan; Moon, Kyuho

Biomolecules & Therapeutics, Vol.31 No.5, pp.566-572

DOI
2024-04
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort
DOI
2024-06
Artificial intelligence-based radiographic extent analysis to predict tuberculosis treatment outcomes: a multicenter cohort study
DOI
2025-01
High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis
DOI
1